Area of research
Complementary and alternative medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Medicine, Internal medicine, Randomized controlled trial, Cancer research, Meta-analysis, and Placebo.
Comparative efficacy and safety of Xuebijing injection as adjuvant therapy in sepsis-associated acute kidney injury: a systematic review and meta-analysis
Risk of Asthma and Allergies in Children Delivered by Cesarean Section: A Comprehensive Systematic Review
Safety of medicinal and edible herbs from fruit sources for human consumption: A systematic review
Role of the tripartite motif‐containing ( <scp>TRIM)</scp> family of proteins in insulin resistance and related disorders
Protocol of a randomized, double-blind, placebo-controlled study of the effect of probiotics on the gut microbiome of patients with gastro-oesophageal reflux disease treated with rabeprazole
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review
Effect and Safety of Acupuncture for Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of 21 Randomised Controlled Trials
Moxibustion for Essential Hypertension and Hypertensive Symptoms: A Systematic Review of 18 Randomized Controlled Trials
Quality and Specific Concerns of Clinical Guidelines for Integrated Chinese and Western Medicine: A Critical Appraisal
Moxibustion as an Adjuvant Therapy for Chronic Kidney Disease: A Systematic Review and Meta‐Analysis of 23 Randomized Controlled Trials
Efficacy and safety of Hou Gu Mi Xi in patients with spleen qi deficiency syndrome who underwent radical gastrectomy for gastric cancer: protocol for a multicenter, randomized, double-blind, placebo-controlled trial
Efficacy and safety of Hou Gu Mi Xi for peptic ulcer diseases
Inhibition of dipeptidyl peptidase IV prevents high fat diet-induced liver cancer angiogenesis by downregulating chemokine ligand 2
Effects of Gua Sha therapy on perimenopausal syndrome: A systematic review and meta-analysis of randomized controlled trials
MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.
PubMed 2017cited by 37position: middle
Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122